Tumour necrosis factor alpha

Description: 
Tumour necrosis factor alpha (TNF-α) is measured in serum as part of the CY19 panel of cytokines. CY19 is composed of the following analytes: IL-1β, IL-6, IL-8 & TNFα.
Clinical details: 
The CY19 cytokine panel is used in various clinical scenarios including aiding identification and treatment of hyper-inflammation syndrome (cytokine storm).
Related condition or disease: 
COVID-19
Reference range: 

6.10 - 13.58

Synonyms or keywords: 
Synonyms: TNF, DIF, TNF-alpha, TNFA, TNFSF2, Tumour necrosis factor, tumor necrosis factor, TNLG1F & Tumor necrosis factor alpha. Key words: Cytokine, COVID-19.
Units: 
pg/ml
Location: 
King's College Hospital
Sample type and Volume required: 
Serum 1ml
Turnaround time: 
7 days
Special sample instructions: 

Separate serum into 2 aliquots

Criteria for acceptance / rejections of sample
Storage and transport: 
Store frozen at -20°C and courier frozen on dry ice
Time limit for extra tests: 
Four weeks
Contacts:
Scientific Research and Innovation Services
Contracts Team: 020 3299 4144; Scientific Team: 020 3229 5548
Scientific Research and Innovation Services
Ground Floor, Bessemer Wing
Kings College Hospital
Denmark Hill
London
SE5 9RS

Contracts Team: kch-tr.synnovis.researchenquiries@nhs.net
Scientific Team: kch-tr.contractrandd@nhs.net
For clinical advice or interpretation of results, please contact the laboratory in the first instance.
Laboratory: 
Scientific Research and Innovation Services

See Scientific Research and Innovation Services for further information

Print as a PDF

Last updated: 26/05/2023